CIK: 0001802528 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 8, 2020
Total Value ($000): $164,882 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 603,517 | $25,499 | 15.5% | $43.17 | -4.6% | COM | 004225108 |
| — | ZOGENIX INC | 971,875 | $24,034 | 14.6% | $37.89 | — | COM NEW | 98978L204 |
| INSM | INSMED INC | 1,020,797 | $16,363 | 9.9% | $20.45 | +15.9% | COM PAR $.01 | 457669307 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 491,390 | $14,710 | 8.9% | $23.03 | +15.1% | COM | 462260100 |
| FOLD | AMICUS THERAPEUTICS INC | 1,340,395 | $12,385 | 7.5% | $9.51 | 0.0% | COM | 03152W109 |
| AXSM | AXSOME THERAPEUTICS INC | 189,598 | $11,154 | 6.8% | $81.48 | 0.0% | COM | 05464T104 |
| — | KARYOPHARM THERAPEUTICS INC | 562,351 | $10,803 | 6.6% | $19.18 | — | COM | 48576U106 |
| ARGX | ARGENX SE | 76,638 | $10,096 | 6.1% | $160.52 | — | SPONSORED ADR | 04016X101 |
| — | NEOLEUKIN THERAPEUTICS INC | 810,073 | $9,219 | 5.6% | $12.32 | — | COM | 64049K104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 169,949 | $8,740 | 5.3% | $61.59 | -13.5% | COM | 29251M106 |
| — | ALLAKOS INC | 178,662 | $7,949 | 4.8% | $81.12 | — | COM | 01671P100 |
| — | TRILLIUM THERAPEUTICS INC | 1,818,181 | $7,345 | 4.5% | $4.04 | — | COM NEW | 89620X506 |
| — | AMARIN CORP PLC | 871,714 | $3,487 | 2.1% | $20.84 | — | SPONS ADR NEW | 023111206 |
| — | KINIKSA PHARMACEUTICALS LTD | 200,125 | $3,098 | 1.9% | $11.83 | — | COM CL A | G5269C101 |